• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bisphosphonates for osteoporosis.

作者信息

Favus Murray J

机构信息

Department of Medicine, University of Chicago, Chicago, IL 60637, USA.

出版信息

N Engl J Med. 2010 Nov 18;363(21):2027-35. doi: 10.1056/NEJMct1004903.

DOI:10.1056/NEJMct1004903
PMID:21083387
Abstract
摘要

相似文献

1
Bisphosphonates for osteoporosis.用于治疗骨质疏松症的双膦酸盐类药物。
N Engl J Med. 2010 Nov 18;363(21):2027-35. doi: 10.1056/NEJMct1004903.
2
[New bone density conservation agents for osteoporosis under research and development: Minodronic acid].正在研发的用于骨质疏松症的新型骨密度保护剂：米诺膦酸
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:417-20.
3
Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.口服抗骨质疏松治疗对绝经后骨质疏松症的持续抗骨折疗效。
Curr Med Res Opin. 2010 Nov;26(11):2553-63. doi: 10.1185/03007995.2010.519658. Epub 2010 Sep 21.
4
Persistence with bisphosphonate therapy in older people.老年人双膦酸盐治疗的持续性
J Am Geriatr Soc. 2006 Jun;54(6):1015-6. doi: 10.1111/j.1532-5415.2006.00758.x.
5
In postmenopausal women with osteoporosis, is zoledronic acid (Reclast) superior in improving T-scores and decreasing fracture rates when compared with placebo?在患有骨质疏松症的绝经后女性中，与安慰剂相比，唑来膦酸（密固达）在改善T值和降低骨折率方面是否更具优势？
J Okla State Med Assoc. 2010 Aug;103(8):374-5.
6
Bisphosphonates for osteoporosis--where do we go from here?用于治疗骨质疏松症的双膦酸盐——我们接下来该何去何从？
N Engl J Med. 2012 May 31;366(22):2048-51. doi: 10.1056/NEJMp1202619. Epub 2012 May 9.
7
[Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].[骨折的绝对风险与世界卫生组织指南。绝经后女性预防骨折药物的选择]
Clin Calcium. 2007 Jul;17(7):1090-6.
8
Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.阿仑膦酸盐和利塞膦酸盐治疗绝经后骨质疏松症的疗效与安全性。
Curr Med Res Opin. 2006 May;22(5):919-28. doi: 10.1185/030079906X100276.
9
Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.拉索昔芬：新药。骨质疏松症：效果不比雷洛昔芬好。
Prescrire Int. 2009 Dec;18(104):247.
10
Emerging issues with bisphosphonates.双膦酸盐类药物的新问题
Rheum Dis Clin North Am. 2006 Nov;32(4):691-702, vi. doi: 10.1016/j.rdc.2006.08.002.

引用本文的文献

1
Long-term bisphosphonate use and femoral morphological changes in osteoporosis patients: a retrospective cohort study.骨质疏松症患者长期使用双膦酸盐与股骨形态学变化：一项回顾性队列研究。
Eur J Med Res. 2025 Jul 1;30(1):536. doi: 10.1186/s40001-025-02764-4.
2
Effect of recombinant human parathyroid hormone and zoledronic acid on osteoblast gene expression using multifaceted approach: An in vitro study.采用多方面方法研究重组人甲状旁腺激素和唑来膦酸对成骨细胞基因表达的影响：一项体外研究。
Indian J Pharmacol. 2025 Mar 1;57(2):69-76. doi: 10.4103/ijp.ijp_582_23. Epub 2025 Jun 13.
3
Sympathetic cholinergic nerve fibres promote BMSC differentiation into osteoblasts via NRTN secretion: a potential treatment for osteoporosis.
交感胆碱能神经纤维通过分泌神经营养因子促进骨髓间充质干细胞向成骨细胞分化：一种骨质疏松症的潜在治疗方法。
J Orthop Surg Res. 2025 Jun 5;20(1):571. doi: 10.1186/s13018-025-05944-4.
4
Molecular mechanisms and treatment strategies for estrogen deficiency-related and glucocorticoid-induced osteoporosis: a comprehensive review.雌激素缺乏相关和糖皮质激素诱导性骨质疏松症的分子机制与治疗策略：综述
Inflammopharmacology. 2025 Apr 28. doi: 10.1007/s10787-025-01749-3.
5
Optimizing bone health with bisphosphonate therapies in pediatric osteogenesis imperfecta: a network meta-analysis of randomized trials.双膦酸盐疗法优化小儿成骨不全症的骨骼健康：一项随机试验的网状Meta分析
Arch Osteoporos. 2025 Mar 6;20(1):33. doi: 10.1007/s11657-025-01515-6.
6
Towards Optimal Automated Ga-Radiolabeling Conditions of the DOTA-Bisphosphonate BPAMD Without Pre-Purification of the Generator Eluate.在不预先纯化发生器洗脱液的情况下实现DOTA-双膦酸盐BPAMD的最佳自动化镓放射性标记条件。
J Labelled Comp Radiopharm. 2024 Dec;67(14):441-453. doi: 10.1002/jlcr.4128. Epub 2024 Nov 20.
7
Targeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis.靶向内质网应激诱导的淋巴功能障碍减轻双膦酸盐相关性骨坏死。
Clin Transl Med. 2024 Nov;14(11):e70082. doi: 10.1002/ctm2.70082.
8
Chimeric antigen receptor dendritic cells targeted delivery of a single tumoricidal factor for cancer immunotherapy.嵌合抗原受体树突状细胞靶向递送单一细胞毒因子用于癌症免疫治疗。
Cancer Immunol Immunother. 2024 Aug 6;73(10):203. doi: 10.1007/s00262-024-03788-1.
9
Osteoporosis: interferon-gamma-mediated bone remodeling in osteoimmunology.骨质疏松症：骨免疫学中的干扰素-γ介导的骨重塑。
Front Immunol. 2024 May 16;15:1396122. doi: 10.3389/fimmu.2024.1396122. eCollection 2024.
10
Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.骨质疏松症及骨质疏松症药物对骨折愈合的影响：叙述性综述。
Osteoporos Int. 2024 Aug;35(8):1337-1358. doi: 10.1007/s00198-024-07059-8. Epub 2024 Apr 8.